Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UPC | US
-0.06
-2.52%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
20/03/2026
2.40
2.26
2.40
2.26
Universe Pharmaceuticals INC a pharmaceutical company engages in the development manufacturing marketing distribution and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers including biomedical drugs medical instruments traditional Chinese medicine pieces products and dietary supplements. Its customers include pharmaceutical companies hospitals clinics and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
77.6%1 month
68.1%3 months
118.1%6 months
159.8%-
-
0.36
0.24
0.13
0.31
0.18
-
-4.92M
56.75M
56.75M
-
-13.51
-82.00
-30.20
-50.22
0.09
1.89
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.91
Range1M
1.05
Range3M
5.20
Rel. volume
0.18
Price X volume
2.46K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 2.83 | 39.89M | -1.74% | n/a | 81.86% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 7.15 | 38.24M | -2.19% | n/a | 0.00% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.7737 | 35.41M | 0.49% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 0.9323 | 35.29M | 4.28% | n/a | 25.73% |
| India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.2862 | 21.65M | 5.22% | n/a | 4.33% |
| Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0505 | 21.21M | -6.48% | n/a | 0.00% |
| PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 2.28 | 5.08M | -0.44% | n/a | -2.89% |
| China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 1.4 | 4.87M | -6.04% | n/a | 19.00% |
| Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 0.87 | 4.82M | 1.68% | n/a | 13.20% |
| Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 2.43 | 3.25M | -0.61% | n/a | 8.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 2.35 | 42.44M | 8.90% | n/a | 5.48% |
| Culp Inc | CULP | Textile Manufacturing | 2.79 | 34.85M | -6.06% | n/a | 11.29% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.58 | 23.09M | -4.82% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5225 | 10.10M | -5.34% | n/a | 58.43% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.4336 | 6.67M | n/a | 422.08% | |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3938 | 3.75M | 0.31% | n/a | 19.98% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.23 | 3.14M | n/a | 17.32% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | -2.34% | n/a | 0.00% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 12.84 | 0 | -0.08% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.31 | - | Cheaper |
| Ent. to Revenue | 0.18 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.36 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 118.09 | - | Riskier |
| Debt to Equity | 0.24 | -1.88 | Expensive |
| Debt to Assets | 0.13 | 0.48 | Cheaper |
| Market Cap | 56.75M | - | Emerging |